Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer and inflammatory diseases. Its structure allows selective modification of purine-based compounds to enhance binding affinity with specific enzyme targets. Commonly employed in medicinal chemistry for developing biologically active molecules due to its ability to mimic natural purine substrates while offering improved metabolic stability. Also utilized in the preparation of labeled compounds for biochemical assays and receptor binding studies.